Skip to content

Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses

Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses Over a Range of Refractive Astigmatism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04613882
Enrollment
59
Registered
2020-11-03
Start date
2021-09-28
Completion date
2022-06-21
Last updated
2023-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The aim of this work is to undertake a range of vision-related measures with soft toric contact lenses soft spherical contact lenses and spectacle lens correction across a range of levels of astigmatism.

Detailed description

This will be a randomised, crossover, partially subject-masked (for contact lenses only), non-dispensing study, controlled by cross-comparison.

Interventions

DEVICESoft Toric Custom Made Contact lens

Subjects will be randomized to wear soft toric custom made lenses for 30 minutes in one eye with other eye patched.

DEVICESoft Spherical Contact Lenses

Subjects will be randomized to wear soft spherical contact lenses for 30 minutes in one eye with other eye patched.

Subjects will be randomized to wear spectacle Correction for 30 minutes in one eye with other eye patched.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

\- Subjects will only be eligible for the study if: 1. They are of legal age between 18 and 40 years. 2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent. 3. They are willing and able to follow the protocol. 4. They are current wearers of any soft contact lens (i.e. have worn lenses in the last six months). 5. They have refractive ocular astigmatism between 0.00DC and -1.50DC in one or both eyes. 6. They have a spherical component to their ocular refractive error between 0.00 and - 6.00 DS. 7. They could attain at least 0.10 logMAR distance high contrast visual acuity in one eye with the study lenses within the available power range. 8. They can be fitted satisfactorily with both lens types. 9. They own an acceptable pair of spectacles. 10. They agree not to participate in other clinical research for the duration of this study.

Exclusion criteria

\- Subjects will not be eligible to take part in the study if: 1. They have an ocular disorder which would normally contra-indicate contact lens wear. 2. They have a systemic disorder which would normally contra-indicate contact lens wear. 3. They are using any topical medication such as eye drops or ointment. 4. They have had corneal refractive surgery. 5. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. 6. They are pregnant or breastfeeding. 7. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear. 8. They have an amblyopic eye, in which case only dominant eye will be assessed for that subject. 9. They have an infectious disease (e.g. hepatitis), any immunosuppressive disease (e.g. HIV) or diabetes. 10. They have a history of severe allergic reaction or anaphylaxis. 11. They have taken part in any other contact lens clinical trial or research, within two weeks prior to starting this study.

Design outcomes

Primary

MeasureTime frameDescription
Visual AcuityBaseline with low contrast VAVisual acuity was assessed using logMAR for each intervention.

Secondary

MeasureTime frameDescription
Slit Lamp Biomicroscopy Findings - Limbal RednessEntrance (Prior to wear of study lens)Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.
Slit Lamp Biomicroscopy Findings - Corneal StainingEntrance (Prior to wear of study lens)Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.
Slit Lamp Biomicroscopy Findings - Conjunctival RednessEntrance (Prior to wear of study lens)Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.
Slit Lamp Biomicroscopy Findings - Papillary ConjunctivitisEntrance (Prior to wear of study lens)Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.
Slit Lamp Biomicroscopy Findings - Corneal OedemaEntrance (Prior to wear of study lens)Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.
Slit Lamp Biomicroscopy Findings - Conjunctival StainingEntrance (Prior to wear of study lens)Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.

Countries

United Kingdom

Participant flow

Pre-assignment details

59 participants were screened for eligibility. Two participants did not meet the inclusion criteria and therefore were not included in the randomization. Each of the 3 interventions were subdivided into 7 cylinder groups based on required astigmatism range. Of the remaining 57 participants, 4 participants were assigned to cylinder groups which were already full and thus they did not receive any of the interventions. The remaining 53 participants completed the study using the three interventions.

Participants by arm

ArmCount
Spherical Contact Lens, Spectacles, Toric Contact Lens
Spherical CL for 30 minutes, then Spectacles for 30 minutes, then Toric CL for 30 minutes
14
Spherical Contact Lens, Spectacles, Toric Contact Lens
Spherical CL for 30 minutes, then Spectacles for 30 minutes, then Toric CL for 30 minutes
23
Spherical Contact Lens, Toric Contact Lens, Spectacles
Spherical CL for 30 minutes, then Toric CL for 30 minutes, then Spectacles for 30 minutes
6
Spherical Contact Lens, Toric Contact Lens, Spectacles
Spherical CL for 30 minutes, then Toric CL for 30 minutes, then Spectacles for 30 minutes
9
Spectacles, Spherical Contact Lens, Toric Contact Lens
Spectacles for 30 minutes, then Spherical CL for 30 minutes, then Toric CL for 30 minutes
9
Spectacles, Spherical Contact Lens, Toric Contact Lens
Spectacles for 30 minutes, then Spherical CL for 30 minutes, then Toric CL for 30 minutes
15
Spectacles, Toric Contact Lens, Spherical Contact Lens
Spectacles for 30 minutes, then Toric CL for 30 minutes, then Spherical CL for 30 minutes
5
Spectacles, Toric Contact Lens, Spherical Contact Lens
Spectacles for 30 minutes, then Toric CL for 30 minutes, then Spherical CL for 30 minutes
6
Toric Contact Lens, Spherical Contact Lens, Spectacles
Toric CL for 30 minutes, then Spherical CL for 30 minutes, then Spectacles for 30 minutes
6
Toric Contact Lens, Spherical Contact Lens, Spectacles
Toric CL for 30 minutes, then Spherical CL for 30 minutes, then Spectacles for 30 minutes
9
Toric Contact Lens, Spectacles, Spherical Contact Lens
Toric CL for 30 minutes, then Spectacles for 30 minutes, then Spherical CL for 30 minutes
13
Toric Contact Lens, Spectacles, Spherical Contact Lens
Toric CL for 30 minutes, then Spectacles for 30 minutes, then Spherical CL for 30 minutes
22
Total137

Baseline characteristics

CharacteristicToric Contact Lens, Spectacles, Spherical Contact LensTotalSpherical Contact Lens, Spectacles, Toric Contact LensSpherical Contact Lens, Toric Contact Lens, SpectaclesSpectacles, Spherical Contact Lens, Toric Contact LensSpectacles, Toric Contact Lens, Spherical Contact LensToric Contact Lens, Spherical Contact Lens, Spectacles
Age, Continuous27.8 years
STANDARD_DEVIATION 6.3
26.5 years
STANDARD_DEVIATION 5.7
26.1 years
STANDARD_DEVIATION 4.8
27.3 years
STANDARD_DEVIATION 5.6
25.9 years
STANDARD_DEVIATION 5
28.2 years
STANDARD_DEVIATION 7.7
25.4 years
STANDARD_DEVIATION 6.7
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
17 Eyes58 Eyes14 Eyes5 Eyes13 Eyes6 Eyes3 Eyes
Sex: Female, Male
Male
5 Eyes26 Eyes9 Eyes4 Eyes2 Eyes0 Eyes6 Eyes

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 57
other
Total, other adverse events
4 / 57
serious
Total, serious adverse events
0 / 57

Outcome results

Primary

Visual Acuity

Visual acuity was assessed using logMAR for each intervention.

Time frame: Baseline with low contrast VA

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsVisual Acuity0.2 logMARStandard Deviation 0.09
Primary

Visual Acuity

Visual acuity was assessed using logMAR for each intervention.

Time frame: After 30 minutes of dispense (Low Contrast VA)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsVisual Acuity0.28 logMARStandard Deviation 0.013
Soft Toric Custom Made Contact LensesVisual Acuity0.24 logMARStandard Deviation 0.09
Spectacle CorrectionVisual Acuity0.21 logMARStandard Deviation 0.09
Primary

Visual Acuity

Visual acuity was assessed using logMAR for each intervention.

Time frame: Baseline with High contrast VA

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsVisual Acuity-0.07 logMARStandard Deviation 0.07
Primary

Visual Acuity

Visual acuity was assessed using logMAR for each intervention.

Time frame: After 30 minutes of dispense (High Contrast VA)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsVisual Acuity-0.02 logMARStandard Deviation 0.11
Soft Toric Custom Made Contact LensesVisual Acuity-0.08 logMARStandard Deviation 0.07
Spectacle CorrectionVisual Acuity-0.1 logMARStandard Deviation 0.06
Secondary

Slit Lamp Biomicroscopy Findings - Conjunctival Redness

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is Exit which refers to those measurements taken post-lens/spectacle wear.

Time frame: At Exit (After 30 minutes in each of three interventions)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Conjunctival Redness1.0 units on a scaleStandard Deviation 0.3
Secondary

Slit Lamp Biomicroscopy Findings - Conjunctival Redness

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.

Time frame: Entrance (Prior to wear of study lens)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Conjunctival Redness1.0 units on a scaleStandard Deviation 0.3
Secondary

Slit Lamp Biomicroscopy Findings - Conjunctival Staining

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is Exit which refers to those measurements taken post-lens/spectacle wear.

Time frame: At Exit (After 30 minutes in each of three interventions)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Conjunctival Staining0.6 units on a scaleStandard Deviation 0.5
Secondary

Slit Lamp Biomicroscopy Findings - Conjunctival Staining

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.

Time frame: Entrance (Prior to wear of study lens)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Conjunctival Staining0.4 units on a scaleStandard Deviation 0.4
Secondary

Slit Lamp Biomicroscopy Findings - Corneal Oedema

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is Exit which refers to those measurements taken post-lens/spectacle wear.

Time frame: At Exit (After 30 minutes in each of three interventions)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Corneal Oedema0.0 units on a scaleStandard Deviation 0
Secondary

Slit Lamp Biomicroscopy Findings - Corneal Oedema

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.

Time frame: Entrance (Prior to wear of study lens)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Corneal Oedema0.0 units on a scaleStandard Deviation 0
Secondary

Slit Lamp Biomicroscopy Findings - Corneal Staining

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is Exit which refers to those measurements taken post-lens/spectacle wear.

Time frame: At Exit (After 30 minutes in each of three interventions)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Corneal Staining0.3 units on a scaleStandard Deviation 0.5
Secondary

Slit Lamp Biomicroscopy Findings - Corneal Staining

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.

Time frame: Entrance (Prior to wear of study lens)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Corneal Staining0.2 units on a scaleStandard Deviation 0.5
Secondary

Slit Lamp Biomicroscopy Findings - Limbal Redness

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is Exit which refers to those measurements taken post-lens/spectacle wear.

Time frame: At Exit (After 30 minutes in each of three interventions)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Limbal Redness0.9 units on a scaleStandard Deviation 0.3
Secondary

Slit Lamp Biomicroscopy Findings - Limbal Redness

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.

Time frame: Entrance (Prior to wear of study lens)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Limbal Redness0.9 units on a scaleStandard Deviation 0.3
Secondary

Slit Lamp Biomicroscopy Findings - Papillary Conjunctivitis

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is Entrance which refers to the time prior to wear of study lens.

Time frame: Entrance (Prior to wear of study lens)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Papillary Conjunctivitis1.1 units on a scaleStandard Deviation 0.3
Secondary

Slit Lamp Biomicroscopy Findings - Papillary Conjunctivitis

Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is Exit which refers to those measurements taken post-lens/spectacle wear.

Time frame: At Exit (After 30 minutes in each of three interventions)

ArmMeasureValue (MEAN)Dispersion
Overall ParticipantsSlit Lamp Biomicroscopy Findings - Papillary Conjunctivitis1.1 units on a scaleStandard Deviation 0.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026